Product information and disease descriptionProduct descriptionProduct informationPharmacology
Pharmacokinetics
7 evidence topics · 3 sources
Absorption, half-life, and clearance after single doses in healthy participants
“Following single oral doses across 5–800 mg, plasma drug concentration–time profiles demonstrated rapid absorption with a median time to maximum concentration (T max) 1.0–1.5 h (Table 3; Figure 1b); the mean terminal half‐life (t 1/2) ranged from 7.9 to 10.5 h, and apparent clearance was comparable, ranging from 18.7 to 27.6 L/h.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The interindividual variability of exposure parameters (C max and AUC0–∞) were low to moderate (<20%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Dose proportionality
“Over the dose range of 5–800 mg of lorundrostat in part 1, dose proportional increases in systemic exposure in terms of AUC0–∞ were observed as the 95% CIs of the slopes for the AUCs vs. dose included the value 1.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In contrast, the estimate of the slope (95% CI) for C max versus dose was 1.104 (1.043–1.164), and a slightly greater than dose proportional increase in C max was observed over the range 5–800 mg (Figure S1).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In addition, systemic exposure in terms of the AUC0–24 and C max appeared to increase in a slightly more than dose proportional manner over the tested multiple‐dose range on Days 1 and 7 (Figure S1).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Steady state and accumulation with once-daily dosing
“A steady state was achieved by approximately Day 5 and very slight accumulation of lorundrostat was observed following multiple dosing compared with Day 1, with the mean rate of accumulation values for AUC0–24 ranging from 1.15 to 1.19 across the entire dose range. Consistent with single‐dose administration, the mean t 1/2 values on Day 7 ranged from 9.1 to 11.9 h.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“After single‐ and multiple‐dose lorundrostat administration, plasma levels peaked 1–3 h after administration with a t 1/2 of 10–12 h.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Renal excretion of unchanged drug
“After a single dose of 40–360 mg of lorundrostat on Day 1, the fraction of the dose excreted in the urine as unchanged was low, with mean values ranging between 1.2%–1.8%. The fraction of the lorundrostat dose excreted remained consistent over the dose range tested. Renal clearance (CLR) was low and generally similar across dose levels (mean CLR ranging between 0.3–0.5 L/h) after a single dose on Day 1.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“After 7 days of once‐daily doses of lorundrostat, the fraction of the dose excreted in the urine as unchanged drug was low for all multiple‐dose levels, with mean values ranging between 2.3% and 2.6%.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Food effect
“Based on the dose escalation data of the first cohort in part 2 where lorundrostat was administered in the fed state, the PK profile did not appear to be affected compared with part 1 where lorundrostat was administered in the fasted state.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Separate from the study we report in this article, a formal food effect study has been conducted and confirms lack of effect of food on the absorption and PK of lorundrostat (tablet formulation; data on file).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Relative exposure of the capsule and tablet formulations
Metabolism, protein binding, and volume of distribution
No evidence found.